pharma · Diabetic Macular Edema · Hypercholesterolemia · REGN
Regeneron UK
Regeneron UK Limited
Regeneron UK trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Tarrytown, USA HQ
16,715 Employees
Public company Type
REGN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tarrytown, USA
- Employees
- 16,715
- Programs
- 5
- Drugs
- 69
- Patents
- 48
Regeneron UK clinical trials
Registry index of 6 ClinicalTrials.gov studies linked to Regeneron UK programs — each row shows trial ID, program name, phase, status, and indication.
Regeneron UK trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Regeneron UK.
-
ziv-aflibercept — Phase 1
Clinical update -
Tirzepatide — Phase 2
Clinical update -
ALN-APOC3 — Phase 1
Clinical update -
ASP8374 — Phase 1
Clinical update -
Alirocumab — Approved
Clinical update -
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
Patent grant -
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
Patent grant